KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of SIOX
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

SIOX Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Feb 08, 2024 Feb 08, 2024 Feb 08, 2024 $0 0%

FAQ

What is the symbol for Sio Gene Therapies Inc Stock and on which exchange is it traded?
The symbol for Sio Gene Therapies Inc is SIOX and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Sio Gene Therapies Inc Stock?
Sio Gene Therapies Inc holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Sio Gene Therapies Inc Stock?
Sio Gene Therapies Inc Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Sio Gene Therapies Inc Stock.

What's the current price of Sio Gene Therapies Inc Stock?
As of the end of day on the Apr 25, 2024, the price of an Sio Gene Therapies Inc (SIOX) share was $0.478.

What is the 52-week high and low for Sio Gene Therapies Inc Stock?
The 52-week high for Sio Gene Therapies Inc Stock is $0.500 and the 52-week low is $0.250.

What is the market capitalization of Sio Gene Therapies Inc Stock?
As of the Apr 25, 2024, the market capitalization of Sio Gene Therapies Inc is 35.36M.
Click to get the best stock tips daily for free!

About Sio Gene Therapies Inc

Sio Gene Therapies Sio Gene Therapies Inc., a clinical-stage company, focuses on developing gene therapies to radically transform the lives of patients with neurodegenerative diseases. It has a license agreement with Oxford BioMedica (UK) Ltd. to develop and commercialize AXO-Lenti-PD and related gene therapy products; and The University of Massachusetts Medical School to develop and commercialize gene therapy product candidates, including AXO-AAV-GM1 and AXO-AAV-G... SIOX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT